{
  "trial_id": "NCT02734498",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "randomly assigned to receive either bilateral electroconvulsive treatment (BL ECT) or right unilateral electroconvulsive treatment (RUL ECT)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients who are otherwise eligible and consent to participate in our study, but refuse ECT (or ones who are unable to consent but their court appointed legal guardian or health care power of attorney refuse ECT) will be enrolled as a control group.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Informed consent will be obtained from the study participant or their legally authorized representative by the principal investigator or sub-investigator.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Prior to treatment each patient will be examined by a clinician (psychiatrist and psychiatric resident) in which the following information will be obtained:",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Psychiatric interview with uniformed questioner",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "History of the present illness (HPI) with onset, course of presenting symptoms, comorbidities, precipitating illness or life events - emphasis upon psychological stress",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Substance abuse screening",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Psychiatric history - Psychiatric diagnoses with age/date of diagnoses",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Medical history, with focus on comorbid developments and chronic medical disease states - especially if recent worsening or change in therapy",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Previous episodes of catatonia - dates and pertinent developments to social history (as noted above with HPI) with time course and treatment response/failure to ECT or medications",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Recent medication changes, with specific focus on timing of symptoms if possible - regimen prior to symptom/sign development, medication changes, and current medication",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Neurological conditions - including Traumatic brain injury (TBI), seizure history, neurodevelopmental disorders, delirium, dementia.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "The Montreal Cognitive Assessment (MOCA) will be administered the day prior to each ECT treatment and the day after each ECT treatment for pre and post procedure cognitive monitoring.",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Pregnant women",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Patients with any of the following medical conditions which are contraindications for ECT:",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Pheochromocytoma",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "History of stroke within the past 3 months",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "notes": "62-year-old African-American man with left upper and lower extremity weakness, associated with dark visual spot in right eye, right facial numbness, facial drop and slurred speech. He has hypertension, hyperlipidemia and hypothyroidism. He smokes cigarette 1 pack per day for 40 years and alcohol consumption of 5 to 6 beers per week.",
  "_meta": {
    "topic_id": "47",
    "trial_id": "NCT02734498",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}